Sentinel lymph node biopsy in patients with a needle core biopsy diagnosis of ductal carcinoma in situ: is it justified?

@article{Doyle2009SentinelLN,
  title={Sentinel lymph node biopsy in patients with a needle core biopsy diagnosis of ductal carcinoma in situ: is it justified?},
  author={Brendan A Doyle and Muhassad H. Al-Mudhaffer and Margaret M. Kennedy and A O'Doherty and Frank M. Flanagan and Enda W. McDermott and Michael J. Kerin and Arnold D. K. Hill and Cecily M. Quinn},
  journal={Journal of clinical pathology},
  year={2009},
  volume={62 6},
  pages={
          534-8
        }
}
BACKGROUND The incidence of ductal carcinoma in situ (DCIS) has increased markedly with the introduction of population-based mammographic screening. DCIS is usually diagnosed non-operatively. Although sentinel lymph node biopsy (SNB) has become the standard of care for patients with invasive breast carcinoma, its use in patients with DCIS is controversial. AIM To examine the justification for offering SNB at the time of primary surgery to patients with a needle core biopsy (NCB) diagnosis of… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 23 CITATIONS